{"altmetric_id":15228986,"selected_quotes":["Valneva $VLA VLA15 phase 1 in Lyme Borreliosis officially fully enrolled (was almost fully enrolled in April)","Valneva $VLA: Lyme phase I started","Valneva $VLA: VLA15 phase I in Lyme appears in the CT registry, starts this month","@sixteen_sheep @gilibugg not recruiting","New OspA-based #LymeDisease vaccine: details on Phase 1 trial in Nebraska Belgium Original OspA patents expired."],"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Valneva Austria GmbH"],"first_seen_on":"2017-01-04T15:05:20+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1501017667,"links":["https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03010228?term=lyme%27s+disease&recr=Open&lup_s=12%2F05%2F2016&lup_d=30&utm_source=dlvr.it&utm_medium=twitter","https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03010228","https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03010228?term=VLA15&rank=1","https:\/\/clinicaltrials.gov\/show\/NCT03010228"],"nct_id":"NCT03010228","pubdate":"2016-12-21T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis","type":"clinical_trial_study_record"},"altmetric_score":{"score":6.55,"score_history":{"1y":6.55,"6m":4.7,"3m":3.7,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":6.55},"context_for_score":{"all":{"total_number_of_other_articles":8272105,"mean":6.9807941447478,"rank":1308603,"this_scored_higher_than_pct":84,"this_scored_higher_than":6960021,"rank_type":"exact","sample_size":8272105,"percentile":84},"similar_age_3m":{"total_number_of_other_articles":270652,"mean":12.402972529198,"rank":62504,"this_scored_higher_than_pct":76,"this_scored_higher_than":207900,"rank_type":"exact","sample_size":270652,"percentile":76},"this_journal":{"total_number_of_other_articles":23981,"mean":10.358652710592,"rank":5956,"this_scored_higher_than_pct":75,"this_scored_higher_than":18019,"rank_type":"exact","sample_size":23981,"percentile":75},"similar_age_this_journal_3m":{"total_number_of_other_articles":784,"mean":15.64574201788,"rank":138,"this_scored_higher_than_pct":82,"this_scored_higher_than":646,"rank_type":"exact","sample_size":784,"percentile":82}}},"demographics":{"poster_types":{"member_of_the_public":6,"researcher":2},"users":{"twitter":{"cohorts":{"Members of the public":6,"Scientists":2}}},"geo":{"twitter":{"FR":2,"DE":1,"US":1,"RE":1}}},"counts":{"total":{"posts_count":11},"twitter":{"unique_users_count":8,"unique_users":["LymeBloggers","BiotechRadar","TchoungTchoung1","portefeuillefun","alanbarbour","citoyen974","dojany","imno6"],"posts_count":11}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/LymeBloggers\/statuses\/816661742663049218","license":"gnip","citation_ids":[15228986],"posted_on":"2017-01-04T15:05:06+00:00","author":{"name":"Lyme Bloggers","url":"http:\/\/lyme.redheadkelly.net\/lyme-blogs\/","image":"https:\/\/pbs.twimg.com\/profile_images\/2580579387\/retro_rss_normal.png","description":"Hundreds of blogs being written by Lyme Disease patients all combined into one feed of the most recent posts.\r\nCompiled by @redheadkelly","id_on_source":"LymeBloggers","tweeter_id":"805413914","geo":{"lt":null,"ln":null},"followers":3490},"tweet_id":"816661742663049218"},{"url":"http:\/\/twitter.com\/BiotechRadar\/statuses\/816712049665441795","license":"gnip","citation_ids":[15228986],"posted_on":"2017-01-04T18:25:01+00:00","author":{"name":"Biotech Radar","image":"https:\/\/pbs.twimg.com\/profile_images\/693444152265146369\/T6cOJomc_normal.png","description":"Anticipate the catalysts of EU biotechs (focus on FR\/BE\/NL\/DE listed in Paris\/Bru.\/Ams.).Views=owner's only.RT\/like =\/= endorsement","id_on_source":"BiotechRadar","tweeter_id":"3142088601","geo":{"lt":46,"ln":2,"country":"FR"},"followers":2497},"tweet_id":"816712049665441795"},{"url":"http:\/\/twitter.com\/TchoungTchoung1\/statuses\/816712605658185728","license":"gnip","rt":["BiotechRadar"],"citation_ids":[15228986],"posted_on":"2017-01-04T18:27:13+00:00","author":{"name":"CTchoung","image":"https:\/\/pbs.twimg.com\/profile_images\/882719324645011457\/zY2JOoHc_normal.jpg","id_on_source":"TchoungTchoung1","tweeter_id":"3323032047","geo":{"lt":48.85341,"ln":2.3488,"country":"FR"},"followers":219},"tweet_id":"816712605658185728"},{"url":"http:\/\/twitter.com\/BiotechRadar\/statuses\/844610562281668608","license":"gnip","citation_ids":[15228986],"posted_on":"2017-03-22T18:03:44+00:00","author":{"name":"Biotech Radar","image":"https:\/\/pbs.twimg.com\/profile_images\/693444152265146369\/T6cOJomc_normal.png","description":"Anticipate the catalysts of EU biotechs (focus on FR\/BE\/NL\/DE listed in Paris\/Bru.\/Ams.).Views=owner's only.RT\/like =\/= endorsement","id_on_source":"BiotechRadar","tweeter_id":"3142088601","geo":{"lt":46,"ln":2,"country":"FR"},"followers":2497},"tweet_id":"844610562281668608"},{"url":"http:\/\/twitter.com\/portefeuillefun\/statuses\/844613755048804362","license":"gnip","rt":["BiotechRadar"],"citation_ids":[15228986],"posted_on":"2017-03-22T18:16:26+00:00","author":{"name":"Schulz","url":"http:\/\/critiquecinematographique.com","image":"https:\/\/pbs.twimg.com\/profile_images\/701617236566523904\/FBtKMQVa_normal.jpg","description":"One day people will say, just why didn't I follow that guy and buy one of his photographs :)","id_on_source":"portefeuillefun","tweeter_id":"427877977","geo":{"lt":51.22172,"ln":6.77616,"country":"DE"},"followers":2756},"tweet_id":"844613755048804362"},{"url":"http:\/\/twitter.com\/alanbarbour\/statuses\/856240872538619904","license":"gnip","citation_ids":[15228986],"posted_on":"2017-04-23T20:18:26+00:00","author":{"name":"Alan Barbour","url":"http:\/\/spiro.mmg.uci.edu","image":"https:\/\/pbs.twimg.com\/profile_images\/621104117943918592\/80hfkwBK_normal.jpg","description":"Physician and scientist; co-discoverer of the cause of #LymeDisease. Research on LD, relapsing fever, and ticks. Author of Lyme Disease @jhupress","id_on_source":"alanbarbour","tweeter_id":"18565050","geo":{"lt":33.66946,"ln":-117.82311,"country":"US"},"followers":95},"tweet_id":"856240872538619904"},{"url":"http:\/\/twitter.com\/BiotechRadar\/statuses\/886990943051808770","license":"gnip","citation_ids":[15228986],"posted_on":"2017-07-17T16:48:14+00:00","author":{"name":"Biotech Radar","image":"https:\/\/pbs.twimg.com\/profile_images\/693444152265146369\/T6cOJomc_normal.png","description":"Anticipate the catalysts of EU biotechs (focus on FR\/BE\/NL\/DE listed in Paris\/Bru.\/Ams.).Views=owner's only.RT\/like =\/= endorsement","id_on_source":"BiotechRadar","tweeter_id":"3142088601","geo":{"lt":46,"ln":2,"country":"FR"},"followers":2497},"tweet_id":"886990943051808770"},{"url":"http:\/\/twitter.com\/portefeuillefun\/statuses\/886993539661484032","license":"gnip","rt":["BiotechRadar"],"citation_ids":[15228986],"posted_on":"2017-07-17T16:58:34+00:00","author":{"name":"Schulz","url":"http:\/\/critiquecinematographique.com","image":"https:\/\/pbs.twimg.com\/profile_images\/701617236566523904\/FBtKMQVa_normal.jpg","description":"One day people will say, just why didn't I follow that guy and buy one of his photographs :)","id_on_source":"portefeuillefun","tweeter_id":"427877977","geo":{"lt":51.22172,"ln":6.77616,"country":"DE"},"followers":2756},"tweet_id":"886993539661484032"},{"url":"http:\/\/twitter.com\/citoyen974\/statuses\/886994665911844864","license":"gnip","rt":["BiotechRadar"],"citation_ids":[15228986],"posted_on":"2017-07-17T17:03:02+00:00","author":{"name":"citoyen & vilain","image":"https:\/\/pbs.twimg.com\/profile_images\/682994528807170049\/kBkCIHai_normal.jpg","description":"vilain fonctionnaire et prof en plus !!!!","id_on_source":"citoyen974","tweeter_id":"470905647","geo":{"lt":-20.88231,"ln":55.4504,"country":"RE"},"followers":191},"tweet_id":"886994665911844864"},{"url":"http:\/\/twitter.com\/dojany\/statuses\/887200268890382337","license":"gnip","rt":["BiotechRadar"],"citation_ids":[15228986],"posted_on":"2017-07-18T06:40:02+00:00","author":{"name":"doubre","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"dojany","tweeter_id":"238900241","geo":{"lt":null,"ln":null},"followers":13},"tweet_id":"887200268890382337"},{"url":"http:\/\/twitter.com\/imno6\/statuses\/889958715268505600","license":"gnip","citation_ids":[15228986],"posted_on":"2017-07-25T21:21:07+00:00","author":{"name":"\u05de\u05e4\u05d2\u05d9\u05df 501","image":"https:\/\/pbs.twimg.com\/profile_images\/889590154435985409\/jrPzQ58n_normal.jpg","description":"\u200f\u200f\u200f\u200f\u200f\u200f\u200f\u200fTo read the whole bio, please press CTRL+W .\u05db\u05dc \u05d4\u05e6\u05d9\u05d5\u05e6\u05d9\u05dd \u05e9\u05dc\u05d9 \u05d4\u05dd \u05e1\u05d0\u05d8\u05d9\u05e8\u05d4 \u05d5\u05d0\u05d9\u05df \u05dc\u05d9\u05d9\u05d7\u05e1 \u05dc\u05d4\u05dd \u05db\u05dc \u05de\u05e9\u05de\u05e2\u05d5\u05ea \u05d0\u05d7\u05e8\u05ea \u05d0\u05dd \u05e0\u05e4\u05d2\u05e2\u05ea \u05de\u05e6\u05d9\u05d5\u05e5 \u05db\u05dc\u05e9\u05d4\u05d5, \u05d0\u05e0\u05d0 \u05e8\u05e9\u05d5\u05dd \u05d0\u05ea \u05ea\u05d2\u05d5\u05d1\u05ea\u05da \u05d5\u05e0\u05e4\u05e8\u05e1\u05de\u05d4 \u05d1\u05de\u05dc\u05d5","id_on_source":"imno6","tweeter_id":"41096337","geo":{"lt":null,"ln":null},"followers":1720},"tweet_id":"889958715268505600"}]}}